Trinity College Dublin

Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

Profile Photo

Professor Thomas Rogers

Chair in Clinical Microbiology/Head of (Clinical Microbiology)

My main research interest is in invasive fungal infections, including molecular diagnostics, pathogenesis, host-pathogen interactions, and antifungal therapies. Also, research into nosocomial infections including Clostridium difficile colitis. Other current research includes study of Escherichia coli bacteraemia focusing on pathogenic mechanisms, epidemiology and antibiotic resistance.
  Antibiotics   Bacteriology and bacterial pathogenesis   Fungal Diseases   Infectious Diseases/Agents   Mycology and fungal pathogenesis   Tuberculosis
 Evaluation of next generation sequencing to investigate the epidemiology of Clostridium difficile infection
 Development of novel management strategies for invasive aspergillosis "MANASP"

Details Date From Date To
President of the Healthcare Infection Society 2010 2014
President Irish Fungal Society 2011 2015
Miajlovic H, Cooke NM, Moran GP, Rogers TR, Smith SG, Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regylated exopolysaccharide colanic acid, Infection and Immunity, 82, 2014, p298 - 305, Journal Article, PUBLISHED
Brown AF, Leech JM, Rogers TR, McLoughlin RM, Staphylococcus aureus colonization: modulation of host immune response and impact on vaccine design, Frontiers in Immunology, 4, 2014, p507-, Journal Article, PUBLISHED
O'Toole RF, Johari BM, Mac Aogain M, Rogers TR, Bower JE, Basu I, Freeman JT, Draft genome sequence of the first isolate of extensively drug resistant Mycobacterium tuberculosis in New Zealand, Genome Announcements, 2, 2014, pe00319-, Journal Article, PUBLISHED
Rogers TR, Morton CO, Springer J, Conneally E, Heinz W, Kenny, C, Frost S, Einsele H, Loeffler J, Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies, British Journal of Haematology, 161, 2013, p517 - 524, Journal Article, PUBLISHED
MM Fitzgibbon, N Gibbons, E Roycroft, S Jackson, J O'Donnell, D O'Flanagan, TR Rogers, A snapshot of genetic lineages of Mycobacterium tuberculosis in Ireland over a two-year period, 2010 and 2011, Eurosurveillance, 18, (3), 2013, p1 - 7, Journal Article, PUBLISHED  TARA - Full Text  URL
NĂ­ Cheallaigh C, Fitzgerald I, Grace J, Jagjit Singh G, El-Eraki N, Gibbons N, Keane J, Rogers TR, Clarke S, Bergin C, Interferon Gamma Release Assays for the Diagnosis of Latent TB Infection in HIV-Infected Individuals in a Low TB Burden Country., PloS one, 8, (1), 2013, pe53330 , Journal Article, PUBLISHED  TARA - Full Text  DOI
CO Morton, M Bouzani, J Loeffler, TR Rogers, Direct interaction studies between Aspergillus fumigatus and human immune cells; what have we learned about pathogenicity and host immunity?, Frontiers in Microbiology, 3, 2012, p1 - 6, Journal Article, PUBLISHED  URL
CO Morton, A de Luca, L Romani, TR Rogers, RT-qPCR detection of Aspergillus fumigatus RNA in vitro and in a murine model of invasive aspergillosis utilizing the PAXgene and Tempus RNA stabilization systems, Medical Mycology, 50, 2012, p661 - 666, Journal Article, PUBLISHED
F Walsh, TR Rogers, Comparison of plasmid mediated quinolone resistance and extended spectrum beta lactamases in third-generation cephalosporin resistant Enterobacteriaceae from four Irish hospitals, Journal of Medical Microbiology, 61, 2012, p142 - 147, Journal Article, PUBLISHED
Morton CO, Clemons KV, Springer J, Mueller JG, Rogers TR, Stevens DA, Kurzai O, Einsele H, Loeffler J., Real-time PCR and quantitative culture for monitoring of experimental Aspergillus fumigatus intracranial infection in neutropenic mice, Journal of Medical Microbiology, E pub, 2011, Journal Article, PUBLISHED

Page 1 of 4


Infections in immunocompromised hosts. Invasive fungal infections. Antifungal therapy. Host pathogen interactions. Escherichia coli bloodstream infection. Antibiotic resistance. Nosocomial infections. Epidemiology of tuberculosis. Diagnostic tests for tuberculosis.